Knowledge Center

Article / Feb 01, 2015

The Time Has Come

Authors:
  • Goncalo Andrade
  • Peter Villax
  • Carla Vozone
Source:
PMPS, 2015, February, pp. 30 - 33

The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.

With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.

Related links

Read article here

Also in the Knowledge Center

Related Content

Capabilities

Providing support for all stages of development and production.

Page
Read more

Devices

Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

Inhalation devices

Hovione’s inhalers offer our business partners access to simple, multipurpose, easy to use, globally competitive alternatives for inhalation delivery devices.

Page
Read more